Morris DL - Search Results

1

2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: possible mechanisms.

Holsapple MP, Morris DL, Wood SC, Snyder NK. Holsapple MP, et al. Among authors: morris dl. Annu Rev Pharmacol Toxicol. 1991;31:73-100. doi: 10.1146/annurev.pa.31.040191.000445. Annu Rev Pharmacol Toxicol. 1991. PMID: 2064388 Review. No abstract available.

2

Characterization of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in B6C3F1 and DBA/2 mice following single and repeated exposures.

Morris DL, Jeong HG, Jordan SD, Kaminski NE, Holsapple MP. Morris DL, et al. Arch Toxicol. 1998 Feb;72(3):157-68. doi: 10.1007/s002040050482. Arch Toxicol. 1998. PMID: 9520139

3

Characterization of the role played by antigen challenge in the suppression of in vivo humoral immunity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Matulka RA, Morris DL, Wood SW, Kaminski NE, Holsapple MP. Matulka RA, et al. Among authors: morris dl. Arch Toxicol. 1997;72(1):45-51. doi: 10.1007/s002040050467. Arch Toxicol. 1997. PMID: 9458190

4

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.

Karras JG, Morris DL, Matulka RA, Kramer CM, Holsapple MP. Karras JG, et al. Among authors: morris dl. Toxicol Appl Pharmacol. 1996 Apr;137(2):275-84. doi: 10.1006/taap.1996.0081. Toxicol Appl Pharmacol. 1996. PMID: 8661353

5

Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes.

Wood SC, Jeong HG, Morris DL, Holsapple MP. Wood SC, et al. Among authors: morris dl. Toxicology. 1993 Jul 28;81(2):131-43. doi: 10.1016/0300-483x(93)90005-d. Toxicology. 1993. PMID: 8378939

6

Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells.

Morris DL, Karras JG, Holsapple MP. Morris DL, et al. Immunopharmacology. 1993 Sep-Oct;26(2):105-12. doi: 10.1016/0162-3109(93)90002-8. Immunopharmacology. 1993. PMID: 8282534

7

Serum modulation of the effects of TCDD on the in vitro antibody response and on enzyme induction in primary hepatocytes.

Morris DL, Jeong HG, Stevens WD, Chun YJ, Karras JG, Holsapple MP. Morris DL, et al. Immunopharmacology. 1994 Mar-Apr;27(2):93-105. doi: 10.1016/0162-3109(94)90044-2. Immunopharmacology. 1994. PMID: 8014031

8

Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: II. The role of the T-lymphocyte.

Dooley RK, Morris DL, Holsapple MP. Dooley RK, et al. Among authors: morris dl. Immunopharmacology. 1990 Jan-Feb;19(1):47-58. doi: 10.1016/0162-3109(90)90026-b. Immunopharmacology. 1990. PMID: 2307581

9

A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update.

Holsapple MP, Snyder NK, Wood SC, Morris DL. Holsapple MP, et al. Among authors: morris dl. Toxicology. 1991;69(3):219-55. doi: 10.1016/0300-483x(91)90184-3. Toxicology. 1991. PMID: 1949050 Review.

10

Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activation.

Morris DL, Holsapple MP. Morris DL, et al. Immunopharmacology. 1991 May-Jun;21(3):171-81. doi: 10.1016/0162-3109(91)90022-q. Immunopharmacology. 1991. PMID: 1917439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results